HRMY
Harmony Biosciences Holdings, Inc.
Platform & Compounding FCF
A-
85.5 / 100 composite
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
-
5yr Avg ROIC
16.6%
-
Operating Margin Trend
-1.01 pp/yr
-
5yr Avg ROE
26.3%
-
5yr Share-Count CAGR
0.2%
-
5yr Revenue CAGR
40.3%
-
Revenue-Growth Years (5)
5/5
-
5yr FCF Margin
34.7%
-
5yr FCF/NI Conversion
1.81x
-
Net Debt / EBITDA
-2.10x
-
Interest Coverage (EBIT/Int)
15.68x
-
Altman Z-Score
5.71
Stability
Weight: 5%
C+
59
-
EPS Volatility (σ/μ)
0.43
-
Negative-Revenue Years (5)
0/5
-
Piotroski F-Score
5
3 of 3 gurus held; 3 trimmed; 1 full exit.
- Holders
- 3
- Avg Δ position
-
-31.1%
- New buys
- 0
- Full exits
- 1